Keywords: genzyme, myozyme, begins, pompe, study, pivotal, trial
Genzyme's Myozyme begins Pompe study
Article | 09 June 2003
A pivotal trial, designated 1602, is underway to evaluate Genzyme's Myozyme, a recombinant human acid alpha-glucosidase enzyme, for the potential treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
